Pseudomembranous Colitis
Pseudomembranous colitis is acute inflammation of the colon secondary to infection with Clostridium difficile – a gram positive toxin-producing anaerobic rod. It has a strong association with prolonged use of broad-spectrum antibiotics, which disrupt the normal bowel flora and allow Clostridium difficile to colonise. The most common culprit antibiotics are 3rd/4th generation cephalosporins, ciprofloxacin, clindamycin, carbapenems and broad-spectrum penicillins. Other risk factors include increased age, prolonged hospital stay, PPI use, immunosuppression and previous Clostridium difficile infection. Symptoms include new onset pungent diarrhoea, abdominal pain, fever, nausea and vomiting. The classification of Clostridium difficile infection severity is shown in table 3:
| Clostridium difficile Disease Severity | Number of loose stools | White Cell Count | Creatinine | Temp >38.5 | Other signs |
|---|---|---|---|---|---|
| Mild | < 3 | Normal | Normal | No | |
| Moderate | 3-5 | Raised but <15 x 10⁹ per litre | Normal | No | |
| Severe | Any | Raised, >15 x 10⁹ per litre | Acute increase >50% above baseline | Yes | Severe abdominal pain
Radiological evidence of severe colitis |
| Life-threatening | Any | Raised, >15 x 10⁹ per litre | Acute increase >50% above baseline | Yes | Hypotension
Partial or complete bowel ileus Toxic Megacolon on abdominal x-ray |
Table 3: Public Health England Classification of Clostridium difficile Infection Severity
Stool samples should be sent for PCR and enzyme immunoassay in all suspected cases of Clostridium difficile. If clinical signs suggest toxic megacolon or bowel perforation, abdominal imaging is necessary. Patients need to be isolated with enhanced PPE for contacts and handwashing with soap and water until 48 hours after diarrhoea has resolved. Care is supportive, with antimicrobial use guided by frequency of reinfection, as shown in table 4.
| Indication | 1st line Management |
|---|---|
| 1st Clostridium difficile infection – mild, moderate or severe infection | Oral Vancomycin 125mg QDS for 10 days |
| Life-threatening Clostridium difficile infection | Oral Vancomycin 500mg QDS for 10 days + IV Metronidazole 500mg TDS for 10 days |
| Recurrent Clostridium difficile infection | Oral Fidaxomicin 200mg BD for 10 days
OR Oral Vancomycin 125mg QDS for 10 days (if >12 weeks of symptom resolution between episodes) |
| 2 or more previous episodes of Clostridium difficile | Consider faecal microbiota transplant |
Table 4: Management of Clostridium difficile Infection in Adults
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.